Biogen Inc. Reports Chief Legal Officer Departure
Summary
Biogen Inc. announced on March 11, 2026, that Susan H. Alexander, Chief Legal Officer, will depart from the Company effective as of the end of May 2026. The Company has initiated a search to identify its next Chief Legal Officer.
Why It Matters
The departure of a Chief Legal Officer represents a change in senior leadership, which can impact legal strategy and corporate governance. Investors will monitor the search for a successor to understand future direction.
These filing summaries are free and always will be. If this helped you spot material events, consider supporting us.
Want to see how BIIB traded around this filing?
Check real-time charts and technical analysis on TradingView to see market reaction to this event.
View BIIB Charts on TradingViewAffiliate link
Is this filing part of a pattern?
One disclosure is noise. Get a structured briefing covering 12 months of SEC filings, disclosure signals, and what to watch next.
Key Quote
“On March 11, 2026, Biogen Inc. (the "Company") announced that Susan H. Alexander, Chief Legal Officer, will depart from the Company effective as of the end May,.”
— From Item 5.02
Filing Details
Reported Items
Additional Information
- CIK Number
- 0000875045
- Filing Date
- Wednesday, March 11, 2026
- Filing Time
- 12:00 AM UTC
- Form Type
- 8-K
- Materiality Level
- high
- Sentiment
- neutral